vimarsana.com

Latest Breaking News On - Shanghai skin disease hospital - Page 1 : vimarsana.com

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA

SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that picankibart (R & D code: IBI112), a recombinant anti-interleukin 23p19 subunit (IL-23p19) antibody injection, has met all.

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA | Taiwan News

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.

Understanding the tumor microenvironment with photoacoustic spectral analysis

Tumors are not just isolated clumps of abnormal cells, but are associated with more complex system known as the "tumor microenvironment" (TME). Over the past few years, research has revealed that the TME consists of a complex combination of blood vessels, connective tissue, and a matrix of extracellular proteins and molecules. Most importantly, the composition of the TME is different from that of nearby healthy tissues. In particular, the lipid and collagen contents of tumors differ from those of normal tissues, making them important potential biomarkers for diagnosing various types of cancers, such as breast, prostate, or skin cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.